Stemtech Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STEK research report →
Companywww.stemtech.com
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands.
- CEO
- Charles S. Arnold
- IPO
- 2021
- Employees
- 1
- HQ
- Naples, FL, US
Price Chart
Valuation
- Market Cap
- $29.23K
- P/E
- -0.01
- P/S
- 0.01
- P/B
- -0.01
- EV/EBITDA
- -1.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 80.38%
- Op Margin
- -48.55%
- Net Margin
- -79.17%
- ROE
- 56.47%
- ROIC
- 43.30%
Growth & Income
- Revenue
- $5.05M · 2.69%
- Net Income
- $-3,769,566 · 30.58%
- EPS
- $-0.03 · 51.15%
- Op Income
- $-2,386,427
- FCF YoY
- 70.47%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.65
- Avg Volume
- 35.25M
Get TickerSpark's AI analysis on STEK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 23, 25 | KAPLAN BENJAMIN NATHANIEL | sell | 1,000,000 |
| Jul 26, 24 | ARNOLD CHARLES STUART | buy | 25,000 |
| Apr 19, 24 | Mindshare Holdings, Inc. | sell | 25,000 |
| Aug 8, 23 | Green Darryl V | other | 1,254,818 |
| Jun 12, 23 | Green Darryl V | other | 2,408,818 |
| Jun 12, 23 | ARNOLD CHARLES STUART | other | 8,333,333 |
Our STEK Coverage
We haven't published any research on STEK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate STEK Report →